Heart disease and stroke statistics—2014 update: a report from the American Heart Association AS Go, D Mozaffarian, VL Roger, EJ Benjamin, JD Berry, MJ Blaha, S Dai, ... circulation 129 (3), e28-e292, 2014 | 31816* | 2014 |
Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease H Schunkert, IR König, S Kathiresan, MP Reilly, TL Assimes, H Holm, ... Nature genetics 43 (4), 333-338, 2011 | 2256 | 2011 |
Genomewide association study of severe Covid-19 with respiratory failure Severe Covid-19 GWAS Group New England Journal of Medicine 383 (16), 1522-1534, 2020 | 2000 | 2020 |
Hypercoagulability of COVID‐19 patients in intensive care unit: a report of thromboelastography findings and other parameters of hemostasis M Panigada, N Bottino, P Tagliabue, G Grasselli, C Novembrino, ... Journal of thrombosis and haemostasis 18 (7), 1738-1742, 2020 | 1586 | 2020 |
Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants Heart Attack Risk in Puget Sound. Schwartz Stephen M 20 26 Siscovick David S ... Nature genetics 41 (3), 334-341, 2009 | 1314 | 2009 |
Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies. M Scully, BJ Hunt, S Benjamin, R Liesner, P Rose, F Peyvandi, B Cheung, ... British journal of haematology 158 (3), 2012 | 1080 | 2012 |
Caplacizumab treatment for acquired thrombotic thrombocytopenic purpura M Scully, SR Cataland, F Peyvandi, P Coppo, P Knöbl, ... New England Journal of Medicine 380 (4), 335-346, 2019 | 877 | 2019 |
Mapping the human genetic architecture of COVID-19 Writing group Writing group leaders Pathak Gita A. 6 Andrews Shea J. 7 Kanai ... Nature 600 (7889), 472-477, 2021 | 805 | 2021 |
Caplacizumab for acquired thrombotic thrombocytopenic purpura F Peyvandi, M Scully, JA Kremer Hovinga, S Cataland, P Knöbl, H Wu, ... New England Journal of Medicine 374 (6), 511-522, 2016 | 661 | 2016 |
Recessively inherited coagulation disorders PM Mannucci, S Duga, F Peyvandi Blood 104 (5), 1243-1252, 2004 | 626 | 2004 |
New susceptibility locus for coronary artery disease on chromosome 3q22. 3 J Erdmann, A Großhennig, PS Braund, IR König, C Hengstenberg, ... Nature genetics 41 (3), 280-282, 2009 | 577 | 2009 |
The past and future of haemophilia: diagnosis, treatments, and its complications F Peyvandi, I Garagiola, G Young The Lancet 388 (10040), 187-197, 2016 | 566 | 2016 |
A randomized trial of factor VIII and neutralizing antibodies in hemophilia A F Peyvandi, PM Mannucci, I Garagiola, A El-Beshlawy, M Elalfy, ... New England Journal of Medicine 374 (21), 2054-2064, 2016 | 550 | 2016 |
Coagulation factor activity and clinical bleeding severity in rare bleeding disorders: results from the European Network of Rare Bleeding Disorders F Peyvandi, R Palla, M Menegatti, SM Siboni, S Halimeh, B Faeser, ... Journal of Thrombosis and Haemostasis 10 (4), 615-621, 2012 | 495 | 2012 |
Consensus on the standardization of terminology in thrombotic thrombocytopenic purpura and related thrombotic microangiopathies M Scully, S Cataland, P Coppo, J De La Rubia, KD Friedman, JK Hovinga, ... Journal of thrombosis and haemostasis 15 (2), 312-322, 2017 | 456 | 2017 |
ADAMTS13 autoantibodies in patients with thrombotic microangiopathies and other immunomediated diseases M Rieger, PM Mannucci, JAK Hovinga, A Herzog, G Gerstenbauer, ... Blood 106 (4), 1262-1267, 2005 | 358 | 2005 |
The thrombogram in rare inherited coagulation disorders: its relation to clinical bleeding R Al Dieri, F Peyvandi, E Santagostino, M Giansily, PM Mannucci, ... Thrombosis and haemostasis 88 (10), 576-582, 2002 | 354 | 2002 |
Evaluation and management of postpartum hemorrhage: consensus from an international expert panel R Abdul‐Kadir, C McLintock, AS Ducloy, H El‐Refaey, A England, ... Transfusion 54 (7), 1756-1768, 2014 | 348 | 2014 |
Rare bleeding disorders: diagnosis and treatment R Palla, F Peyvandi, AD Shapiro Blood, The Journal of the American Society of Hematology 125 (13), 2052-2061, 2015 | 342 | 2015 |
Role of von Willebrand factor in the haemostasis F Peyvandi, I Garagiola, L Baronciani Blood Transfusion 9 (Suppl 2), s3, 2011 | 336 | 2011 |